Empagliflozin alters lipid metabolism in the myocardium and liver in a prediabetes model with severe dyslipidemia
Article in Frontiers in Pharmacology (July 2024)
The most recent citing publications are shown below. View all 11 publications that cite this research output on Dimensions.
Deciphering mortality risk of diabetes medications in heart failure patients with diabetes mellitus under triple guideline-directed medical therapy
Article in International Journal of Cardiology (May 2024)
Cardiovascular outcomes and molecular targets for the cardiac effects of Sodium-Glucose Cotransporter 2 Inhibitors: A systematic review
Article in Biomedicine & Pharmacotherapy (April 2024)